Karsten Fischer is the founder of Memo Therapeutics. Memo Therapeutics has raised $69M in total funding. Latest round: Series C.
Karsten Fischer is the Co-founder and CEO of Memo Therapeutics AG, a late-stage biotech company focused on developing therapeutic antibodies. He leads the company's antibody discovery engine and oversees clinical development for AntiBKV. Fischer has been key in securing funding, including Series B and Series C rounds, to advance the company's clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library